Difficulty: Medium
Average Score: 89%
Practice
Angiotensin-converting enzyme inhibitors are contraindicated in
Correct answer
D
Rationale
In pharmacology, angiotensin-converting enzyme (ACE) inhibitors are contraindicated in pregnant women due to their potential to cause harm to the developing fetus. ACE inhibitors can lead to fetal malformations, particularly affecting the renal system, when used during pregnancy. This can result in serious complications for both the mother and the baby.
Option A, high renin hypertensives, is incorrect because ACE inhibitors are actually beneficial in this population due to their ability to block the renin-angiotensin-aldosterone system, leading to vasodilation and reduced blood pressure.
Option B, diabetics, is incorrect as ACE inhibitors are commonly used in diabetic patients to help protect the kidneys and reduce the risk of diabetic nephropathy.
Option C, congestive heart failure patients, is also incorrect as ACE inhibitors are a mainstay in the treatment of heart failure due to their ability to improve outcomes and reduce mortality in these patients.
Educationally, understanding the contraindications of medications is crucial for safe and effective patient care. Students and healthcare professionals must be aware of which patient populations may be at risk for adverse effects from certain drugs to make informed decisions about treatment options. In the case of ACE inhibitors, knowing that they are contraindicated in pregnant women is essential to avoid potential harm to both the mother and the developing fetus.
Option A, high renin hypertensives, is incorrect because ACE inhibitors are actually beneficial in this population due to their ability to block the renin-angiotensin-aldosterone system, leading to vasodilation and reduced blood pressure.
Option B, diabetics, is incorrect as ACE inhibitors are commonly used in diabetic patients to help protect the kidneys and reduce the risk of diabetic nephropathy.
Option C, congestive heart failure patients, is also incorrect as ACE inhibitors are a mainstay in the treatment of heart failure due to their ability to improve outcomes and reduce mortality in these patients.
Educationally, understanding the contraindications of medications is crucial for safe and effective patient care. Students and healthcare professionals must be aware of which patient populations may be at risk for adverse effects from certain drugs to make informed decisions about treatment options. In the case of ACE inhibitors, knowing that they are contraindicated in pregnant women is essential to avoid potential harm to both the mother and the developing fetus.